PDT Partners’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-33,400
Closed -$242K 514
2019
Q2
$242K Buy
33,400
+19,440
+139% +$133K 0.01% 355
2019
Q1
$92K Buy
+13,960
New +$92K 0.01% 416
2018
Q3
Sell
-21,216
Closed -$1.2M 569
2018
Q2
$1.2M Buy
21,216
+1,406
+7% +$71.3K 0.05% 310
2018
Q1
$838K Sell
19,810
-1,900
-9% -$81.6K 0.03% 375
2017
Q4
$1.16M Buy
+21,710
New +$1.15M 0.03% 352
2015
Q3
Sell
-1,310
Closed -$201K 1719
2015
Q2
$201K Sell
1,310
-2,035
-61% -$336K 0.01% 1239
2015
Q1
$571K Buy
+3,345
New +$507K 0.01% 962
2013
Q4
Sell
-1,797
Closed -$290K 1330
2013
Q3
$290K Buy
+1,797
New +$283K 0.01% 1263

Other funds holding ELGX

PDT Partners's ELGX Position: Q3 2019 in Review

PDT Partners sold out of Endologix Inc (ELGX) in Q3 2019, closing a stake of 33,400 shares — an estimated $242K sold.

PDT Partners first reported a position in ELGX in Q3 2013 and held it in 8 quarters. The position peaked at $1.2M in Q2 2018. 63 funds tracked by Wall St. Rank hold ELGX as of Q3 2019.

  • PDT Partners reported no remaining Endologix Inc position as of Q3 2019 after selling out during the quarter.
  • PDT Partners sold 33,400 Endologix Inc shares in Q3 2019, an estimated $242K.
  • PDT Partners first reported a position in Endologix Inc in Q3 2013 and held it in 8 quarters.
  • PDT Partners's Endologix Inc position peaked at $1.2M in Q2 2018.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2019.

Based on PDT Partners's 13F filing for Q3 2019, filed 14 Nov 2019.